HCW Biologics Inc. Common Stock
Veridion Score
Composite trend over time
Why is HCWB moving today?
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for HCWB.
HCWB insider activity
HCW Biologics Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for HCWB.
HCWB contract awards, year to date.
Public federal awards linked to this ticker.
HCWB lobbying filings, year to date.
Registered lobbying filings matched to HCW Biologics Inc. Common Stock.